Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly opens phase I study of LY-3435151 in advanced solid tumors

Nov. 7, 2019

Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia

Nov. 7, 2019

New phase I trial explores BI-1701963 in KRAS-mutated advanced or metastatic solid tumors

Nov. 7, 2019

Boehringer Ingelheim reports data on new SOS1-KRAS interaction inhibitors for cancer

Nov. 7, 2019

Schizophrenia biomarker can be detected in human hair

Nov. 7, 2019

Sanofi Pasteur presents preclinical data for ZIKV vaccine ZPIV-SP

Nov. 7, 2019

ABSK-041, a highly potent and orally available small-molecule PD-L1 antagonist

Nov. 7, 2019

Adagene presents first-in-human data for ADG-106

Nov. 7, 2019

Early clinical data presented for AGIL-AADC gene therapy in children with AADC deficiency

Nov. 7, 2019

Vaccibody announces preliminary phase I/IIa data for VB10.NEO neoantigen cancer vaccine

Nov. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...